Impact of hemolysis on multiomic pancreatic cancer biomarker discovery: De-risking precision medicine biomarker development

被引：0
|
作者：
Kiebish, Michael A. [1 ]
Shah, Punit [1 ]
Bussberg, Valerie [1 ]
Tolstikov, Vladimir [1 ]
Searfoss, Rick [1 ]
Ofori-Mensa, Kennedy [1 ]
Grund, Eric M. [1 ]
Darkwah, Abena [1 ]
Chen, Emily Y. [1 ]
Greenwood, Bennett [1 ]
Ntoso, Ellaine Adu [1 ]
Rodrigues, Leonardo [1 ]
Liu, Mia [1 ]
Granger, Elder [1 ]
Bountra, Chas [2 ]
Sarangarajan, Rangaprasad [1 ]
Moser, A. J. [3 ]
Narain, Niven R. [1 ]
机构：
[1] BERG LLC, Framingham, MA USA
[2] Univ Oxford, Oxford, England
[3] Harvard Med Sch, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2860
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2860
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies
    Richard Searfoss
    Punit Shah
    Kennedy Ofori-Mensa
    Valerie Bussberg
    Vladimir Tolstikov
    Bennett Greenwood
    Hongyan Li
    Kris Richardson
    Gregory M. Miller
    Corinne DeCicco
    Elder Granger
    Leonardo O. Rodrigues
    Eric M. Grund
    A. James Moser
    Rangaprasad Sarangarajan
    Niven R. Narain
    Michael A. Kiebish
    Scientific Reports, 12
  • [2] Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies
    Searfoss, Richard
    Shah, Punit
    Ofori-Mensa, Kennedy
    Bussberg, Valerie
    Tolstikov, Vladimir
    Greenwood, Bennett
    Li, Hongyan
    Richardson, Kris
    Miller, Gregory M.
    DeCicco, Corinne
    Granger, Elder
    Rodrigues, Leonardo O.
    Grund, Eric M.
    Moser, A. James
    Sarangarajan, Rangaprasad
    Narain, Niven R.
    Kiebish, Michael A.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Cancer Biomarker Discovery for Precision Medicine: New Progress
    Zou, Jinfeng
    Wang, Edwin
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (42) : 7655 - 7671
  • [4] De-risking the discovery and development of new drugs from bench to clinic
    Ilyin, SE
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (11) : 1031 - 1031
  • [5] Multiomic analysis workflow for biomarker discovery in human prostate cancer
    Cilento, Michael A.
    Mah, Chui Yan
    Martelotto, Luciano
    Sweeney, Christopher J.
    Butler, Lisa M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 79 - 80
  • [6] De-Risking Drug Discovery with ADDME - Avoiding Drug Development Mistakes Early
    Tsaioun, Katya
    Jacewicz, Mary
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2009, 37 : 47 - 55
  • [7] Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
    Beger, Richard D.
    Schmidt, Michael A.
    Kaddurah-Daouk, Rima
    METABOLITES, 2020, 10 (04)
  • [8] Introduction to this Special Issue: "Biomarker Discovery and Precision Medicine"
    Fang, Bingliang
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [9] Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
    Diaz, Paola Monterroso
    Leehans, Ashton
    Ravishankar, Prashanth
    Daily, Anna
    BIOMARKER INSIGHTS, 2023, 18
  • [10] Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies
    Ijeoma Adaku Umelo
    Brunella Costanza
    Vincent Castronovo
    Cancer and Metastasis Reviews, 2018, 37 : 125 - 145
12345